Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL2028441

C[n+]1ccn(CC=CF)c1.O=S(=O)([O-])C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FDPS P14324 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.33
LMNA P02545 1/20 0.33
MEN1 O00255 1/20 0.33
APAF1 O14727 1/20 0.33
NPC1 O15118 1/20 0.33
PLA2G1B P04054 1/20 0.33
HSP90AA1 P07900 1/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
ATG4B Q9Y4P1 1/20 0.33
KCNH2 Q12809 6/20 0.30
ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL4920095 0.84 FDPS (0.37) FDPSSMN1; SMN2LMNAMEN1APAF1
Trifluoromethanesulfonic Acid SCHEMBL133213 0.80 FDPS (0.40) FDPSSMN1; SMN2LMNAMEN1APAF1
Trifluoromethanesulfonic Acid SCHEMBL16668993 0.80 FDPS (0.36) FDPSSMN1; SMN2LMNAMEN1APAF1
Trifluoromethanesulfonic Acid SCHEMBL2679835 0.79 FDPS (0.46) FDPSSMN1; SMN2LMNAMEN1APAF1
Trifluoromethanesulfonic Acid SCHEMBL319658 0.78 SMN1; SMN2 (0.49) FDPSSMN1; SMN2LMNAMEN1APAF1
Trifluoromethanesulfonic Acid SCHEMBL2914064 0.77 SMN1; SMN2 (0.41) FDPSSMN1; SMN2LMNAMEN1APAF1
Trifluoromethanesulfonic Acid SCHEMBL27174984 0.77 FDPS (0.44) FDPSSMN1; SMN2LMNAMEN1APAF1
Trifluoromethanesulfonic Acid SCHEMBL4553127 0.75 FDPS (0.40) FDPSSMN1; SMN2LMNAMEN1APAF1
Trifluoromethanesulfonic Acid SCHEMBL294105 0.75 MEN1 (0.58) FDPSSMN1; SMN2MEN1APAF1NPC1
Trifluoromethanesulfonic Acid SCHEMBL15768578 0.75 FDPS (0.40) FDPSSMN1; SMN2LMNAMEN1APAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7960554-B2 Ambient-temperature molten salts and process for producing the same TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2011-06-14 US disclosed
US-7534509-B2 Ambient-temperature molten salts and process for producing the same TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2009-05-19 US disclosed
US-20070225503-A1 Ambient-temperature molten salts and process for producing the same TOYOTA JIDOSHA KABUSHIKI KAISHA 2007-09-27 US disclosed
US-20070203345-A1 Ambient-temperature molten salts and process for producing the same TOYOTA JIDOSHA KABUSHIKI KAISHA 2007-08-30 US disclosed
US-20060094882-A1 Ambient-temperature molten salts and process for producing the same TOYOTA JIDOSHA KABUSHIKI KAISHA 2006-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203345-A1 Ambient-temperature molten salts and process for producing the same AFF1, AFF2, AFF4 FDPS 605/4885SMN1; SMN2 886/4885LMNA 3669/4885
US-20070225503-A1 Ambient-temperature molten salts and process for producing the same AFF1, AFF2, AFF4 FDPS 605/4885SMN1; SMN2 886/4885LMNA 3669/4885
US-20060094882-A1 Ambient-temperature molten salts and process for producing the same AFF1, AFF2, AFF4 FDPS 605/4885SMN1; SMN2 872/4885LMNA 3686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.